Morgan Stanley
OYST

Morgan Stanley’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Morgan Stanley’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,986
Closed -$89.2K – 8009
2022
Q4 		$89.2K Sell
7,986
-136,542
-94% -$1.32M ﹤0.01% 6032
2022
Q3 		$812K Buy
144,528
+477
+0.3% +$2.99K ﹤0.01% 5001
2022
Q2 		$623K Buy
144,051
+39,302
+38% +$223K ﹤0.01% 5308
2022
Q1 		$1.22M Buy
104,749
+32,206
+44% +$383K ﹤0.01% 4863
2021
Q4 		$1.32M Sell
72,543
-45,185
-38% -$573K ﹤0.01% 4879
2021
Q3 		$1.4M Buy
117,728
+91,566
+350% +$1.33M ﹤0.01% 4833
2021
Q2 		$450K Sell
26,162
-17,211
-40% -$327K ﹤0.01% 5593
2021
Q1 		$793K Sell
43,373
-37,523
-46% -$787K ﹤0.01% 4873
2020
Q4 		$1.52M Buy
80,896
+21,587
+36% +$466K ﹤0.01% 4385
2020
Q3 		$1.25M Buy
59,309
+23,275
+65% +$544K ﹤0.01% 4047
2020
Q2 		$1.04M Buy
36,034
+35,599
+8,184% +$1.07M ﹤0.01% 4142
2020
Q1 		$15K Sell
435
-7,115
-94% -$230K ﹤0.01% 5917
2019
Q4 		$185K Buy
+7,550
New +$133K ﹤0.01% 5449

Other funds holding OYST

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Morgan Stanley's OYST Position: Q1 2023 in Review

Morgan Stanley sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 7,986 shares — an estimated $89.2K sold.

Morgan Stanley first reported a position in OYST in Q4 2019 and held it in 13 quarters. The position peaked at $1.52M in Q4 2020. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

  • Morgan Stanley reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Morgan Stanley sold 7,986 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $89.2K.
  • Morgan Stanley first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 13 quarters.
  • Morgan Stanley's Oyster Point Pharma, Inc. Common Stock position peaked at $1.52M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.